385 related articles for article (PubMed ID: 37400008)
61. Melatonin improves cholestatic liver disease via the gut-liver axis.
Liu X; Li J; Shi M; Fu J; Wang Y; Kang W; Liu J; Zhu F; Huang K; Chen X; Liu Y
J Pineal Res; 2024 Jan; 76(1):e12929. PubMed ID: 38047407
[TBL] [Abstract][Full Text] [Related]
62. [Effect of geniposidic acid on hepato-enteric circulation in cholestasis rats through Sirt1-FXR signaling pathway].
Chen H; Li J; Hu L; Zhao W; Yu H; Liu HZ; Ma ST
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):787-795. PubMed ID: 30989893
[TBL] [Abstract][Full Text] [Related]
63. Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis.
van de Wiel SMW; Porteiro B; Belt SC; Vogels EWM; Bolt I; Vermeulen JLM; de Waart DR; Verheij J; Muncan V; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 May; 4(5):100463. PubMed ID: 35462858
[TBL] [Abstract][Full Text] [Related]
64. The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis.
Santamaría E; Rodríguez-Ortigosa CM; Uriarte I; Latasa MU; Urtasun R; Alvarez-Sola G; Bárcena-Varela M; Colyn L; Arcelus S; Jiménez M; Deutschmann K; Peleteiro-Vigil A; Gómez-Cambronero J; Milkiewicz M; Milkiewicz P; Sangro B; Keitel V; Monte MJ; Marin JJG; Fernández-Barrena MG; Ávila MA; Berasain C
Hepatology; 2019 Apr; 69(4):1632-1647. PubMed ID: 30411380
[TBL] [Abstract][Full Text] [Related]
65. MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.
Kim YC; Jung H; Seok S; Zhang Y; Ma J; Li T; Kemper B; Kemper JK
Hepatology; 2020 Jun; 71(6):2118-2134. PubMed ID: 31549733
[TBL] [Abstract][Full Text] [Related]
66. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
[TBL] [Abstract][Full Text] [Related]
67. Effects of Sedi Herba (Sedum sarmentosum) on attenuating cholestasis by the activation of the farnesoid x receptor (FXR)-mediated signaling.
Liu Z; Liu D; Chen M; Zong W; Zhou X; Meng F; Jiang Y; Chen M; Liao Z; Wang G
Biomed Pharmacother; 2022 Nov; 155():113803. PubMed ID: 36271579
[TBL] [Abstract][Full Text] [Related]
68. D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress.
Zhao SS; Li NR; Zhao WL; Liu H; Ge MX; Zhang YX; Zhao LY; You XF; He HW; Shao RG
Acta Pharmacol Sin; 2018 Feb; 39(2):213-221. PubMed ID: 28748913
[TBL] [Abstract][Full Text] [Related]
69. [Study on protective effect of Chaihu Shugan Powder against liver injury in rats with intrahepatic cholestasis by regulating FXR/Nrf2/ARE pathway].
Lou J; Zhao L; Zhu YJ; Yuan SQ; Wang F; Zhang HZ; Xu JJ; Yu XK; Hou LF
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5610-5616. PubMed ID: 36471979
[TBL] [Abstract][Full Text] [Related]
70. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.
Zhang G; Sun X; Wen Y; Shi A; Zhang J; Wei Y; Wu X
Eur J Pharmacol; 2020 Oct; 885():173498. PubMed ID: 32841642
[TBL] [Abstract][Full Text] [Related]
71. [Study on protective mechanism of Tibetan medicine Ershiwuwei Songshi Pills on cholestatic liver injury in rats based on FXR signaling pathway].
Yan-Xi LI; Xiao-Peng LI; Jian GU; Jia-Chuan LI; Pu-Yang G; Zhi-Long S; Qi MA
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(21):5273-5279. PubMed ID: 33350245
[TBL] [Abstract][Full Text] [Related]
72. Danning tablets attenuates α-naphthylisothiocyanate-induced cholestasis by modulating the expression of transporters and metabolic enzymes.
Ding L; Zhang B; Zhan C; Yang L; Wang Z
BMC Complement Altern Med; 2014 Jul; 14():249. PubMed ID: 25033983
[TBL] [Abstract][Full Text] [Related]
73. Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury.
Shearn CT; Anderson AL; Miller CG; Noyd RC; Devereaux MW; Balasubramaniyan N; Orlicky DJ; Schmidt EE; Sokol RJ
Hepatol Commun; 2023 Jan; 7(1):e0020. PubMed ID: 36633484
[TBL] [Abstract][Full Text] [Related]
74. Targeted bile acid profiles reveal the liver injury amelioration of Da-Chai-Hu decoction against ANIT- and BDL-induced cholestasis.
Zhou Y; Zhou Y; Li Y; Sun W; Wang Z; Chen L; He Y; Niu X; Chen J; Yao G
Front Pharmacol; 2022; 13():959074. PubMed ID: 36059946
[TBL] [Abstract][Full Text] [Related]
75. [Effects of Li-Dan-He-Ji on regulating oxidative stress and antagonising infantile cholestatic hepatic fibrosis].
Yi W; Yan S; Tang J; Ma X; Su M; Li H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jul; 35(7):741-745. PubMed ID: 37545453
[TBL] [Abstract][Full Text] [Related]
76. Plumbagin ameliorates bile duct ligation-induced cholestatic liver injury in rats.
Pan PH; Wang YY; Lin SY; Liao SL; Chen YF; Huang WC; Chen CJ; Chen WY
Biomed Pharmacother; 2022 Jul; 151():113133. PubMed ID: 35594710
[TBL] [Abstract][Full Text] [Related]
77. Mechanistic studies on the alleviation of ANIT-induced cholestatic liver injury by Polygala fallax Hemsl. polysaccharides.
Guan G; Cao H; Tang Z; Zhang K; Zhong M; Lv R; Wan W; Guo F; Wang Y; Gao Y
J Ethnopharmacol; 2024 Jun; 328():118108. PubMed ID: 38574780
[TBL] [Abstract][Full Text] [Related]
78. Identifying hepatoprotective mechanism and effective components of Yinchenzhufu decoction in chronic cholestatic liver injury using a comprehensive strategy based on metabolomics, molecular biology, pharmacokinetics, and cytology.
Li Y; Peng X; Wang G; Zan B; Wang Y; Zou J; Tian T; Meng Q; Shi R; Wang T; Wu J; Ma Y
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117060. PubMed ID: 37598769
[TBL] [Abstract][Full Text] [Related]
79. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
He H; Mennone A; Boyer JL; Cai SY
Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
[TBL] [Abstract][Full Text] [Related]
80. Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism via an FXR-dependent manner.
Huang W; Qian Y; Lin J; Wang F; Kong X; Tan W
Biochem Biophys Res Commun; 2024 Apr; 705():149670. PubMed ID: 38442444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
